Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-25, Stock:JNJ, The news for the past five days is as follows:
2018-05-18: NEWS1: Congo's Ebola not an international emergency, can be controlled -WHO.NEWS2: Notable Friday Option Activity: ICPT, JNJ, CELG.NEWS3: Notable Friday Option Activity: ICPT, JNJ, CELG.NEWS4: Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug.NEWS5: Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug.NEWS6: Eli Lilly’s Valuation on May 17.NEWS7: Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug.NEWS8: Johnson & Johnson scraps Alzheimer's trials on safety concerns.NEWS9: Dow 30 Stock Roundup: Walmart, Cisco, Home Depot Beat on Earnings.NEWS10: Dow 30 Stock Roundup: Walmart, Cisco, Home Depot Beat on Earnings.NEWS11: US birth rates hit record low and diaper, baby bottle companies are feeling the pinch.NEWS12: Why J&J's Stock May Plunge 10%.
2018-05-21: NEWS1: It’s Not as Bad as It Looks for Johnson & Johnson Stock.NEWS2: It’s Not as Bad as It Looks for Johnson & Johnson Stock.NEWS3: How to Play the Long Side of Johnson & Johnson.NEWS4: Should The FDA Be Shaming Drug Companies? Financial Advisors' Daily Digest.NEWS5: Should The FDA Be Shaming Drug Companies? Financial Advisors' Daily Digest.NEWS6: It’s Not as Bad as It Looks for Johnson & Johnson Stock.NEWS7: 7 ‘Blue-Chip Stocks’ That Aren’t Blue Chips at All.NEWS8: 3 Days Left To Cash In On Johnson & Johnson (NYSE:JNJ) Dividend, Is It Worth Buying?.NEWS9: Today's Research Reports on Trending Tickers: Johnson & Johnson and The Procter & Gamble.NEWS10: The Week Ahead In Biotech: PDUFA Dates, IPOs And More.NEWS11: A Look into Roche Holding’s Performance in Q1 2018.
2018-05-22: NEWS1: Will China Erase Birth Limits? Stocks & ETFs to Watch.NEWS2: Will China Erase Birth Limits? Stocks & ETFs to Watch.NEWS3: JNJ’s Baby Care Line Set for Relaunch to Stimulate Falling Sales.NEWS4: How Are Tesaro’s Valuations and Cash Flows?.NEWS5: Glaxo and J&J's Two-Drug HIV Regimen Juluca Gets EU Approval.NEWS6: Glaxo and J&J's Two-Drug HIV Regimen Juluca Gets EU Approval.NEWS7: Wall Street Sees Upside of More than 17% for JNJ in the Next Year.NEWS8: Gauging the Upside Potential of Vertex Pharmaceuticals Stock.NEWS9: Glaxo and J&J&apos;s Two-Drug HIV Regimen Juluca Gets EU Approval.NEWS10: Roche’s Blockbuster Drug: Rituxan and Avastin in Q1 2018.NEWS11: Chinese investors lead another monster round into this early cancer detection company.
2018-05-23: NEWS1: J&J hit with $21.7 million verdict in another talc asbestos cancer case.NEWS2: J&J Loses Second Talc-Asbestos Trial and Damages May Grow.NEWS3: Why Geron Corporation Stock Is Heating Up.NEWS4: Why Geron Corporation Stock Is Heating Up.NEWS5: Why Geron Corporation Stock Is Heating Up.NEWS6: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS7: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS8: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS9: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS10: Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis.NEWS11: Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis.NEWS12: Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis.NEWS13: Why the world needs more than one Ebola vaccine.NEWS14: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS15: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS16: Merck’s experimental and unlicensed Ebola vaccine is being used in latest outbreak.NEWS17: Is This Stock the Next Biotech Acquisition Target?.NEWS18: Is This Stock the Next Biotech Acquisition Target?.NEWS19: Is This Stock the Next Biotech Acquisition Target?.
2018-05-24: NEWS1: Jury recommends $25M in Johnson & Johnson lawsuit.NEWS2: Jury recommends $25M in Johnson & Johnson lawsuit.NEWS3: Novartis Gets Approval for Remicade Biosimilar in Europe.NEWS4: Novartis Gets Approval for Remicade Biosimilar in Europe.NEWS5: Jury awards $25M in Johnson & Johnson baby powder lawsuit.NEWS6: 5 Top Stock Trades for Friday Morning.NEWS7: 3 Pros, 3 Cons to Buying Medtronic PLC Stock.NEWS8: 3 Pros, 3 Cons to Buying Medtronic PLC Stock.NEWS9: J&J must pay $4 million in punitive damages in latest asbestos cancer trial.NEWS10: California Jury Delivers $25.75 Million Verdict in Asbestos Case Tying Johnson's Baby Powder to Mesothelioma.NEWS11: 3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More.NEWS12: 3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More.NEWS13: 3 Big Pharma Stocks with Huge Future Growth Potential.NEWS14: 3 Big Pharma Stocks with Huge Future Growth Potential.NEWS15: An ETF Play For Quality Stocks At A Fair Price.NEWS16: J&J Verdict Reaches Almost $26 Million in Baby Powder Trial.NEWS17: J&J Ordered to Pay $4 Million Punitive Award in Asbestos Suit.NEWS18: Vanguard Total Stock Market ETF Experiences Big Inflow.NEWS19: Vanguard Total Stock Market ETF Experiences Big Inflow.NEWS20: 3 Pros, 3 Cons to Buying Medtronic PLC Stock.NEWS21: Willams-Sonoma, Deutsche Bank and Johnson & Johnson are the Yahoo Finance charts of the day..NEWS22: 3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More.NEWS23: Biopharma M&A: You Ain't Seen Nothing Yet.NEWS24: 3 Big Pharma Stocks with Huge Future Growth Potential.NEWS25: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 25, 2018.NEWS26: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 25, 2018.NEWS27: Stocks making the biggest moves premarket: BBY, MDT, HRL, MCK, DEO, FOXA, F, GM & more.NEWS28: Ex-Dividend Alert: Johnson & Johnson Boosted its Dividend by 7.1%; Will Trade Ex-Dividend on May 25, 2018.

Answer: Decrease